How can I create a concise assessment and plan note for a 47-year-old man with alcohol-related cirrhosis, recent variceal hemorrhage treated with endoscopic band ligation, grade 3‑4 hepatic encephalopathy, acute kidney injury consistent with hepatorenal syndrome, anemia, and a normal head CT?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Assessment and Plan: 47-year-old man with decompensated alcohol-related cirrhosis

Assessment

47M with alcohol-related cirrhosis, ACLF with:

  • Recent variceal hemorrhage s/p EBL
  • Grade 3-4 hepatic encephalopathy
  • AKI consistent with hepatorenal syndrome
  • Anemia (post-hemorrhage)
  • Head CT negative for structural lesions

Plan

1. Hepatic Encephalopathy (Grade 3-4)

ICU-level care is indicated for Grade 3-4 HE 1. This patient requires:

  • Lactulose (oral or rectal) as first-line empiric therapy 1

    • If NG tube needed, use caution given recent EBL 1
    • If ileus develops, hold oral lactulose and use lactulose enema (300 mL lactulose in 700 mL water) 1
    • Goal: improved mental status while monitoring electrolytes to prevent dehydration/hypernatremia

  • Identify and treat precipitants 1:

    • GI bleeding (already treated with EBL)
    • AKI/HRS (see below)
    • Infection (empiric antibiotics reasonable given high risk)
    • Electrolyte disorders
    • Alcohol withdrawal (consider benzodiazepines if indicated) 1

  • Avoid routine ammonia levels - not recommended for diagnosis 1

  • Head CT already done - appropriate given first episode or if focal findings, but routine imaging not warranted for recurrent typical presentations 1

2. Hepatorenal Syndrome-AKI

Terlipressin is first-line therapy for HRS-AKI 2, 3:

  • Reverses HRS in 39% vs 18% with placebo 2
  • Goal: reverse renal failure and bridge to transplant evaluation 3
  • Monitor volume status and electrolytes closely 4

Treat precipitants:

  • Volume expansion with albumin
  • Avoid nephrotoxins
  • Treat infection aggressively (present in 25% of decompensated cirrhosis) 4

3. Post-Variceal Hemorrhage Management

Secondary prophylaxis required 5, 6:

  • Non-selective beta-blockers (carvedilol or propranolol) once hemodynamically stable 2, 6
    • Reduces decompensation/death (16% vs 27% placebo) 2
  • Repeat EBL sessions until variceal eradication 5, 6
  • Consider pre-emptive TIPS if high-risk features present 5

Monitor for post-EBL ulcer bleeding:

  • Occurs in 2.7-7.8% of patients, typically 10-14 days post-procedure 7
  • Mortality 25-50% if occurs 7
  • No indication for prophylactic blood products - not recommended 7

4. Anemia

  • Transfuse PRBCs if hemodynamically unstable or Hgb <7 g/dL
  • Monitor for rebleeding
  • Avoid over-transfusion (increases portal pressure)

5. Alcohol Use Disorder

  • Assess for alcohol withdrawal - common cause of altered mental status that can synergize with HE 1
  • Benzodiazepines if withdrawal present 1
  • Minimize opioids and sedatives (worsen HE) 1
  • Alcohol cessation counseling when mental status improves

6. Liver Transplant Evaluation

Urgent evaluation indicated:

  • Multiple decompensating events (variceal bleeding, HE, HRS)
  • Median survival with HE and ascites: 0.92-1.1 years 2
  • HRS without treatment: median survival <2 weeks 2

7. Monitoring

  • Daily: mental status (West Haven criteria), renal function, electrolytes, CBC
  • Bowel movements (goal 2-3 soft stools/day with lactulose)
  • Hemodynamic stability
  • Signs of infection

Key Pitfalls to Avoid:

  • Do not delay lactulose for HE while searching for other causes 1
  • Do not give prophylactic blood products before/after EBL 7
  • Do not use long-acting sedatives if intubation needed (use propofol/dexmedetomidine) 1
  • Do not overlook alcohol withdrawal as HE contributor 1
  • Do not delay terlipressin for HRS-AKI 2, 3

References

Related Questions

In a 47-year-old patient with alcohol use disorder, cirrhosis, recent variceal bleed status post banding, presenting with altered mental status, elevated blood urea nitrogen, acute kidney injury (creatinine 2.7 mg/dL), elevated lactate, hemoglobin 10 g/dL, and a normal head computed tomography, what is the appropriate management?
What are the recommended assessments and management steps for a patient with liver cirrhosis, including evaluation of etiology, prophylaxis for portal hypertension, treatment of ascites and hepatic encephalopathy, variceal bleeding prevention, and hepatocellular carcinoma surveillance?
What is the recommended management for a 70‑year‑old female with diabetes mellitus and chronic liver disease complicated by ascites, portal hypertension with varices, and hepatic encephalopathy?
In a 65-year-old man with cirrhosis due to chronic hepatitis C presenting with worsening ascites, oliguria, hypotension, hyponatremia, rapidly rising serum creatinine, very low urinary sodium, ascitic fluid not meeting spontaneous bacterial peritonitis criteria, and a normal renal ultrasound while on furosemide and spironolactone, what is the most likely diagnosis: acute interstitial nephritis, acute glomerulonephritis, acute tubular necrosis, or hepatorenal syndrome?
What is the best management approach for an 80-year-old female patient with suspected cirrhosis and low probability of chronic advanced chronic liver disease (cACLD)?
What should the insulin-to-carbohydrate ratio for the 8 am NPH insulin dose be in a 62‑year‑old female with type 2 diabetes, weight 43.8 kg, on prednisone 20 mg daily, using 22 units NPH insulin and current ICR 15 for breakfast and lunch, given her recent blood glucose readings?
What is the interpretation and recommended management for a patient with vital capacity (VC) 61% predicted, forced expiratory volume in one second (FEV1) 55% predicted, and diffusing capacity of the lung for carbon monoxide (TLCO) 39% predicted?
What are the recommended management steps for a patient who fell on her knee two weeks ago, with X‑ray showing mild osteoarthritis and no acute changes, who will be walking extensively on a vacation in three weeks?
Will levofloxacin (Levaquin) 750 mg by mouth daily provide adequate empiric coverage for a dialysis patient with hospital‑acquired pneumonia?
In a 46-year-old woman with a uterus and a history of cerebrovascular accident secondary to carotid artery stenosis, is it safe to prescribe low‑dose vaginal estradiol without adding progesterone?
In a COPD patient with normal arterial blood gases at rest and during exercise, adequate oxygen saturation, and a markedly reduced diffusing capacity (TLCO ≈40% predicted), what is the recommended management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.